GTBPVSMAAS• 3 Months (Normalized)
GTBP vs MAAS (GT Biopharma Inc. vs Maase Inc.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1291.7%
GT Biopharma Inc.
Normalized Baseline0.00%
MAAS Performance $17.82
+%
Maase Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1291.7 pts
GTBP outperforming by 1291.70 percentage points
GTBPMAAS
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP MAAS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | GTBP Price | GTBP Gain (%) | MAAS Price | MAAS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1291.70% | $- | - | |
| Sep 28, 2026 | $6.80 | +1276.52% | $17.82 | +14.08% | +1262.44% |
| Sep 25, 2026 | $6.89 | +1294.74% | $15.37 | -1.60% | +1296.34% |
| Sep 24, 2026 | $6.83 | +1282.59% | $14.03 | -10.18% | +1292.77% |
| Sep 23, 2026 | $7.10 | +1337.25% | $15.06 | -3.59% | +1340.84% |
| Sep 22, 2026 | $- | $14.90 | -4.61% | - | |
| Sep 21, 2026 | $7.18 | +1353.44% | $15.86 | +1.54% | +1351.90% |
| Sep 18, 2026 | $7.16 | +1349.39% | $16.82 | +7.68% | +1341.71% |
| Sep 17, 2026 | $7.49 | +1416.19% | $16.20 | +3.71% | +1412.48% |
| Sep 16, 2026 | $7.81 | +1480.97% | $16.83 | +7.75% | +1473.22% |
| Sep 15, 2026 | $9.00 | +1721.86% | $17.01 | +8.90% | +1712.96% |
| Sep 14, 2026 | $11.63 | +2254.25% | $16.34 | +4.61% | +2249.64% |
| Sep 11, 2026 | $8.61 | +1642.91% | $15.79 | +1.09% | +1641.82% |
| Sep 10, 2026 | $6.18 | +1151.01% | $15.67 | +0.32% | +1150.69% |
| Sep 09, 2026 | $5.98 | +1110.53% | $15.02 | -3.84% | +1114.37% |
Page 1 of 5